Chebani R, Lombart F, Chaby G, Dadban A, et al. Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients. Br J Dermatol 2024;190:258-265.
PMID: 37792727